Patience has its virtues.
Jaguar is currently in the process of reinventing itself, at least to some degree. Like many automakers, it intends to adopt electric propulsion for its entire lineup beginning in 2025. But what will happen until then? Its current lineup is aging fast; the F-Type, for example, launched for the 2014 model year.
French language publication Le Monde claims the UK-based automaker will not launch any new models until 2025. The existing lineup status quo is expected to largely remain, which makes sense given that every model recently received a significant refresh. That should keep things steady until those new EVs begin rolling out in around three years' time. The multi-year new model break will give Jaguar the freedom to enact its roughly €3 billion "Reimagine" plan.
But the big question is what those new EVs are going to be. The I-Pace will need to be replaced sooner or later and what would Jaguar be if it didn't have a two-seater in the mix? An all-electric F-Type successor, if done right, could be extraordinary.
We also expect a next-generation fully-electrified XJ, though it'll have little to nothing in common with the XJ EV that was axed at nearly the last minute by the company's new CEO, Thierry Bollore. He determined it simply wasn't competitive against the likes of the Porsche Taycan and Audi e-tron GT. Starting from scratch is the best thing long-term.
Above all, Bollore is repositioning Jaguar as a more upmarket brand aimed at the highest spec models from BMW, Mercedes, and Audi. It's a bold and risky move for sure. Plus, it involves the discontinuation of the F-Pace SUV, currently Jaguar's best-seller. The smaller E-Pace will also drive off into the sunset come 2025. Jaguar's decision to cease launching new models also means it's simplifying the existing lineup.
For example, the F-Type is now V8-only; the supercharged V6 is gone. It's also down to a single sedan from having three not long ago. The midsize XF isn't new but last year's update gave it new life. There's now a three-month waitlist in the US.